18d
GlobalData on MSNFDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detectionEngineered to specifically act on the vascular endothelial growth factor receptor 2 (VEGFR2), BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection claims to i ...
BR55 injection, an investigational contrast agent for ultrasounds ... Chief Medical and Regulatory Officer, Bracco Imaging Group. “This Fast Track designation supports our goal to get BR55 ...
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying active inflammation in individuals with Crohn's disease. Credit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results